Regenerative Medicine Firm Reports Early Results from COVID-19 Trials
Source: Streetwise Reports  (6/17/20)
Pluristem Therapeutics' coronavirus clinical studies and financing are discussed in a Dawson James report. More >

Biopharma Launches Trial Testing Nitric Oxide as COVID-19 Treatment
Source: Streetwise Reports  (6/17/20)
The design, timeline and takeaways of Beyond Air's study are presented in a ROTH Capital Partners report. More >

Biotech Makes 'Significant Progress' Creating Highly Accurate COVID-19 Antibody Test
Source: Streetwise Reports  (6/17/20)
ProMIS Neurosciences states that the current version of the ProMIS-BCNI assay achieves 99.9% sensitivity and 99.5% specificity for SARS CoV-2, the coronavirus causing COVID-19. More >

Eli Lilly Trades Up 15% on Positive Phase 3 Breast Cancer Trial Results
Source: Streetwise Reports  (6/16/20)
Eli Lilly shares set a new 52-week high price after the company reported that its Verzenio® (abemaciclib) significantly reduced the risk of cancer returning in people with high risk HR+, HER2- early breast cancer. More >

Digital Health Company Growth Continues with Acquisition of BC Medical Clinic
Source: Streetwise Reports  (6/15/20)
CloudMD reported that it has signed a binding agreement to acquire a British Columbia medical clinic with 12 on-staff physicians in a cash and stock deal valued at CA$700,000. More >

Life Sciences Firm Expands Collaboration Efforts with Major U.S. University to Develop Psilocybin-Based Medicines
Source: Streetwise Reports  (6/15/20)
Revive Therapeutics Ltd. reported it has expanded its research partnership for novel formulation development and clinical research of psilocybin with the University of Wisconsin-Madison. More >

Edesa Shares Double Upon Gaining Approval to Initiate Phase 2/3 COVID-19 Study
Source: Streetwise Reports  (6/15/20)
Shares of Edesa Biotech traded more than 100% higher after the company reported that it had received regulatory approval from Health Canada to initiate a Phase 2/3 study of its investigational drug EB05 in COVID-19. More >

Reata Pharma Announces $350 Million Strategic Investment from Blackstone Life Sciences
Source: Streetwise Reports  (6/11/20)
Shares of Reata Pharmaceuticals traded 30% higher after reporting that Blackstone Life Sciences will invest $350 million in the company to advance bardoxolone methyl as a potential therapy for Alport syndrome and other rare and serious chronic kidney diseases. More >

Life Sciences Firm Pursues Phase 3 COVID-19 Treatment Trial in Canada
Source: Streetwise Reports  (6/10/20)
Revive Therapeutics met with Health Canada to discuss how best to proceed. More >

Curis' Shares Take Off as FDA Clears IND Application for Monoclonal Anti-VISTA Antibody
Source: Streetwise Reports  (6/10/20)
Curis Inc. shares are up more than 130% and established a new 52-week high price after reporting that the FDA cleared the company's IND Application for CI-8993, its monoclonal anti-VISTA antibody. More >

Coverage Initiated on Company at 'Forefront of the Telehealth Revolution'
Source: Streetwise Reports  (6/8/20)
A review of CloudMD Software & Services and the reasons why it makes a compelling investment are provided in a Beacon Securities report. More >

Enochian Shares Trade Up 50% upon Concluding FDA Meeting for Potential HIV Cure
Source: Streetwise Reports  (6/8/20)
Shares of Enochian Biosciences reached a new 52-week high after the company reported that it successfully completed its FDA INTERACT meeting for ENOB-HV-01, a potential cure for HIV. More >

Aurora Cannabis 'Upside Breakout Looks Imminent'
Source: Clive Maund for Streetwise Reports  (6/8/20)
Technical analyst Clive Maund charts the cannabis company and explains why he calls it an "immediate strong buy." More >

Mackie Research: Small Cap a World Leader in Health and Safety Wearables
Source: Bill Newman of Mackie Research for Streetwise Reports  (6/5/20)
Mackie Research believes Blockchain Holdings' TraceSafe tracking platform could tap into the "exceptionally large market" for contact tracing during the Covid-19 pandemic. More >

FDA Greenlights Biopharma for Trial of Possible COVID-19 Therapeutic
Source: Streetwise Reports  (6/4/20)
Algernon Pharmaceuticals prepares to commence the Phase 2b study as soon as possible. More >

Micro-Cap Pharma Moving Ahead with Plans for Phase 3 US Trial of a Repurposed Drug for Covid-19
Source: Streetwise Reports  (6/3/20)
Revive Therapeutics is focused on infectious diseases as well as treatments using psilocybin-based formulations. More >

Telemedicine Firm Achieves Record Revenue in Q1/20
Source: Streetwise Reports  (6/3/20)
Also during the quarter, CloudMD Software & Services completes an acquisition, releases an app and upgrades its stock listing. More >

COVID-19: A Catalyst for Small-Cap Outperformance
Source: Steve Palmer for Streetwise Reports  (6/3/20)
Steve Palmer, president and chief investment officer of AlphaNorth Asset Management, outlines why he believes Canadian companies on the TSX Venture Index remain good investments in a time of pandemic uncertainty. More >

Immunotherapy Firm Releases Data Showing Treatment Potential Against Sepsis
Source: Streetwise Reports  (6/3/20)
Recently presented results from Enlivex Therapeutics' Phase 1b study in sepsis and their implications are reviewed in an H.C. Wainwright & Co. report. More >

AI Firm Receives Grant to Create Deep Learning Tools to Enhance Organ Donation Processes
Source: Streetwise Reports  (6/3/20)
Xtract AI has secured a CA$150,000 grant from the Innovative Solutions Canada program to utilize artificial intelligence to increase organ donations and improve transplant success rates. More >

Cassava Shares Rise on Updated Phase 2b Alzheimer's Drug Trial Data
Source: Streetwise Reports  (6/3/20)
Shares of Cassava Sciences traded 70% higher after the firm provided updates from its Phase 2b study of PTI-125 for use in treating Alzheimer' disease. More >

Virtual Healthcare Tech Firm Reports Q3 FY20 Revenue Up 359% YOY
Source: Streetwise Reports  (6/1/20)
Demand for Reliq Health Technologies' offerings continues to grow due to the COVID-19 pandemic. More >

Myovant Sciences Shares Rise on NDA Filing for Uterine Fibroid Combination Therapy Drug
Source: Streetwise Reports  (6/1/20)
Shares of Myovant Sciences traded 40% higher after the company reported that it has submitted a New Drug Application to the FDA for once-daily relugolix combination tablet for the treatment of women with uterine fibroids. More >

AI Firm Develops Tool That Helps Radiologists Diagnose COVID-19
Source: Streetwise Reports  (5/30/20)
Patriot One Technologies and its partners have created a model that automatically calculates, from a radiological scan, the degree of a patient's affected lungs, a COVID-19 indicator. More >

Small-Cap Pharma Fast-Tracking Repurposed Drug for Covid-19
Source: Streetwise Reports  (5/27/20)
Algernon Pharmaceuticals is quickly moving ahead with a multinational Phase 2b/3 trial for Ifenprodil. More >